Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 200

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist

Open access
Thépaut, Michel, Luczkowiak, Joanna, Vivès, Corinne, Labiod, Nuria, Bally, Isabelle, Lasala, Fátima, Grimoire, Yasmina, Fenel, Daphna, Sattin, Sara, Thielens, Nicole, Schoehn, Guy, Bernardi, Anna, Delgado, Rafael, Fieschi, Franck·2021·PLOS Pathogens

Published version of a preprint

Abstract

The efficient spread of SARS-CoV-2 resulted in a unique pandemic in modern history. Despite early identification of ACE2 as the receptor for viral spike protein, much remains to be understood about the molecular events behind viral dissemination. We evaluated the contribution of C-type lectin receptors (CLR S ) of antigen-presenting cells, widely present in respiratory mucosa and lung tissue. DC-SIGN, L-SIGN, Langerin and MGL bind to diverse glycans of the spike using multiple interaction areas. Using pseudovirus and cells derived from monocytes or T-lymphocytes, we demonstrate that while virus capture by the CLRs examined does not allow direct cell infection, DC/L-SIGN, among these receptors, promote virus transfer to permissive ACE2 + Vero E6 cells. A glycomimetic compound designed against DC-SIGN, enable inhibition of this process. These data have been then confirmed using authentic SARS-CoV-2 virus and human respiratory cell lines. Thus, we described a mechanism potentiating viral spreading of infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1009576

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 83

  1. TBH Geijtenbeek, 2009, Signalling through C-type lectin receptors: shaping immune responses, Nat Rev Immunol, 9, 465, 10.1038/nri2569 · DOI · Paper page
  2. O Takeuchi, 2010, Pattern Recognition Receptors and Inflammation, Cell, 140, 805, 10.1016/j.cell.2010.01.022 · DOI · Paper page
  3. MAWP de Jong, 2010, C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi, Mol Immunol, 47, 1216, 10.1016/j.molimm.2009.12.016 · DOI
  4. Y van Kooyk, 2003, DC-SIGN: escape mechanism for pathogens, Nat Rev Immunol, 3, 697, 10.1038/nri1182 · DOI · Paper page
  5. ME Mnich, 2020, C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens, Front Cell Infect Microbiol, 10, 309, 10.3389/fcimb.2020.00309 · DOI
  6. W Van Breedam, 2014, Bitter-sweet symphony: glycan-lectin interactions in virus biology, FEMS Microbiol Rev, 38, 598, 10.1111/1574-6976.12052 · DOI · Paper page
  7. SJ van Vliet, 2007, Innate signaling and regulation of Dendritic cell immunity, Curr Opin Immunol, 19, 435, 10.1016/j.coi.2007.05.006 · DOI · Paper page
  8. SJ van Vliet, 2008, Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses, Immunol Cell Biol, 86, 580, 10.1038/icb.2008.55 · DOI · Paper page
  9. CP Alvarez, 2002, C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans, J Virol, 76, 6841, 10.1128/JVI.76.13.6841-6844.2002 · DOI · Paper page
  10. DL Carbaugh, 2019, Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis, J Virol, 93, e00113, 10.1128/JVI.00113-19 · DOI
  11. TB Geijtenbeek, 2000, DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells, Cell, 100, 587, 10.1016/S0092-8674(00)80694-7 · DOI · Paper page
  12. F Halary, 2002, Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection, Immunity, 17, 653, 10.1016/S1074-7613(02)00447-8 · DOI · Paper page
  13. E Navarro-Sanchez, 2003, Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses, EMBO Rep, 4, 723, 10.1038/sj.embor.embor866 · DOI · Paper page
  14. L de Witte, 2008, Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission, Trends Mol Med, 14, 12, 10.1016/j.molmed.2007.11.001 · DOI
  15. SA Jeffers, 2004, CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus, Proc Natl Acad Sci, 101, 15748, 10.1073/pnas.0403812101 · DOI · Paper page
  16. A Marzi, 2004, DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus, J Virol, 78, 12090, 10.1128/JVI.78.21.12090-12095.2004 · DOI · Paper page
  17. Z-Y Yang, 2004, pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN, J Virol, 78, 5642, 10.1128/JVI.78.11.5642-5650.2004 · DOI · Paper page
  18. C Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
  19. P Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
  20. AC Walls, 2020, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page
  21. E Petersen, 2020, Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics, Lancet Infect Dis, 20, e238, 10.1016/S1473-3099(20)30484-9 · DOI · Paper page
  22. M Backovic, 2012, Virus entry: old viruses, new receptors, Curr Opin Virol, 11
  23. Y Watanabe, 2020, Site-specific glycan analysis of the SARS-CoV-2 spike, Science, eabb9983
  24. Y Watanabe, 2020, Vulnerabilities in coronavirus glycan shields despite extensive glycosylation, Nat Commun, 11, 2688, 10.1038/s41467-020-16567-0 · DOI · Paper page
  25. L Casalino, 2020, Shielding and Beyond: The Roles of Glycans in SARS-CoV-2 Spike Protein, bioRxiv
  26. P Zhao, 2020, Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor, bioRxiv
  27. A Brufsky, 2020, DC/L-SIGNs of hope in the COVID-19 pandemic, J Med Virol, jmv.25980
  28. Y Jia, 2020, Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity, bioRxiv
  29. DH Katz, 2020, Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19, Infectious Diseases (except HIV/AIDS)
  30. C Lucas, 2020, Longitudinal immunological analyses reveal inflammatory misfiring in severe COVID-19 patients, Infectious Diseases (except HIV/AIDS)
  31. M Relloso, DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-␤, and Anti-Inflammatory Agents, J Immunol., 10
  32. OC Grant, 2020, Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition, bioRxiv
  33. M Sikora, 2020, Map of SARS-CoV-2 spike epitopes not shielded by glycans, bioRxiv
  34. LA Hussain, 1995, Comparative investigation of Langerhans’ cells and potential receptors for HIV in oral, genitourinary and rectal epithelia, Immunology, 85, 475
  35. G Tabarani, 2009, DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain, J Biol Chem, 284, 21229, 10.1074/jbc.M109.021204 · DOI
  36. MM Maalej, 2019, The human macrophage galactose-type lectin, MGL, recognizes the outer core of E. coli lipooligosaccharide, ChemBioChem, cbic.201900087, 10.1002/cbic.201900087 · doi:10.1002/cbic.201900087
  37. M Thépaut, 2009, Structural studies of langerin and Birbeck granule: a macromolecular organization model, Biochemistry, 48, 2684, 10.1021/bi802151w · DOI
  38. H Feinberg, 2005, Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR, J Biol Chem, 280, 1327, 10.1074/jbc.M409925200 · doi:10.1074/jbc.m409925200
  39. A Marzi, 2007, Analysis of the Interaction of Ebola Virus Glycoprotein with DC-SIGN (Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin) and Its Homologue DC-SIGNR, J Infect Dis, 196, S237, 10.1086/520607 · DOI
  40. Z Yang, 1998, Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins, Science, 279, 1034, 10.1126/science.279.5353.1034 · DOI · Paper page
  41. S Ordanini, 2015, Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods, Chem Commun Camb Engl, 51, 3816, 10.1039/C4CC09709B · doi:10.1039/c4cc09709b
  42. A Berzi, 2016, Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants, Sci Rep, 6, 35373, 10.1038/srep35373 · DOI
  43. V Porkolab, 2020, Development of C-type lectin-oriented surfaces for high avidity glycoconjugates: towards mimicking multivalent interactions on the cell surface, Org Biomol Chem, 18, 4763, 10.1039/D0OB00781A · doi:10.1039/d0ob00781a
  44. AA Lambert, 2008, The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways, Blood, 112, 1299, 10.1182/blood-2008-01-136473 · DOI · Paper page
  45. B Lee, 2001, cis Expression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor, J Virol, 75, 12028, 10.1128/JVI.75.24.12028-12038.2001 · DOI · Paper page
  46. P Liu, 2017, Beyond attachment: Roles of DC-SIGN in dengue virus infection, Traffic Cph Den
  47. Tseligka Cagno, 2019, Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?, HeparanViruses, 11, 596
  48. M Bermejo-Jambrina, 2018, C-Type Lectin Receptors in Antiviral Immunity and Viral Escape, Front Immunol, 9, 590, 10.3389/fimmu.2018.00590 · DOI · Paper page
  49. D Perez-Zsolt, 2019, Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry, Nat Microbiol, 4, 1558, 10.1038/s41564-019-0453-2 · DOI
  50. A Milewska, 2014, Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells, J Virol, 88, 13221, 10.1128/JVI.02078-14 · DOI · Paper page
  51. MA Tortorici, 2019, Structural basis for human coronavirus attachment to sialic acid receptors, Nat Struct Mol Biol, 26, 481, 10.1038/s41594-019-0233-y · DOI · Paper page
  52. DP Han, 2007, Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry, J Virol, 81, 12029, 10.1128/JVI.00315-07 · DOI
  53. F Chiodo, 2020, Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2, Spike Protein to Host Lectins and Lung Microbiota. bioRxiv
  54. A-J Behrens, 2017, Structural principles controlling HIV envelope glycosylation, Curr Opin Struct Biol, 44, 125, 10.1016/j.sbi.2017.03.008 · DOI
  55. P Valverde, 2020, Molecular recognition in C-type lectins: the cases of DC-SIGN, Langerin, MGL, and L-sectin, ChemBioChem, cbic.202000238
  56. H Feinberg, 2001, Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR, Sci N Y NY, 294, 2163, 10.1126/science.1066371 · DOI · Paper page
  57. A Cambi, 2004, Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells, J Cell Biol, 164, 145, 10.1083/jcb.200306112 · DOI · Paper page
  58. AW Mesman, 2012, A Prominent Role for DC-SIGN+ Dendritic Cells in Initiation and Dissemination of Measles Virus Infection in Non-Human Primates, PLoS ONE, 7, e49573, 10.1371/journal.pone.0049573 · doi:10.1371/journal.pone.0049573
  59. AW Mesman, 2014, Measles Virus Suppresses RIG-I-like Receptor Activation in Dendritic Cells via DC-SIGN-Mediated Inhibition of PP1 Phosphatases, Cell Host Microbe, 16, 31, 10.1016/j.chom.2014.06.008 · DOI
  60. J-J Liang, 2018, DC-SIGN Binding Contributed by an Extra N-Linked Glycosylation on Japanese Encephalitis Virus Envelope Protein Reduces the Ability of Viral Brain Invasion, Front Cell Infect Microbiol, 8
  61. EP Go, 2011, Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry, J Virol, 85, 8270, 10.1128/JVI.05053-11 · DOI
  62. NF Parrish, 2013, Phenotypic properties of transmitted founder HIV-1, Proc Natl Acad Sci, 110, 6626, 10.1073/pnas.1304288110 · DOI · Paper page
  63. TW Geisbert, 2003, Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques, Am J Pathol, 163, 2347, 10.1016/S0002-9440(10)63591-2 · DOI · Paper page
  64. O Martinez, 2012, The role of antigen-presenting cells in filoviral hemorrhagic fever: Gaps in current knowledge, Antiviral Res, 93, 416, 10.1016/j.antiviral.2012.01.011 · DOI
  65. A Lüdtke, 2017, Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination, Sci Rep, 7, 43776, 10.1038/srep43776 · DOI
  66. L Tailleux, 2005, DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis, PLoS Med, 2, e381, 10.1371/journal.pmed.0020381 · DOI · Paper page
  67. A Dominguez-Soto, 2007, The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells, Blood, 109, 5337, 10.1182/blood-2006-09-048058 · DOI
  68. I Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570 · DOI · Paper page
  69. R Amraie, 2020, CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells, bioRxiv
  70. L de Witte, 2007, Langerin is a natural barrier to HIV-1 transmission by Langerhans cells, Nat Med, 13, 367, 10.1038/nm1541 · DOI · Paper page
  71. F Schmidt, 2020, Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses, J Exp Med, 217, e20201181, 10.1084/jem.20201181 · DOI · Paper page
  72. L Yang, 2020, COVID-19: immunopathogenesis and Immunotherapeutics, Signal Transduct Target Ther, 5, 128, 10.1038/s41392-020-00243-2 · DOI · Paper page
  73. M Relloso, 2002, DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents, J Immunol, 168, 2634, 10.4049/jimmunol.168.6.2634 · DOI · Paper page
  74. D Blanco-Melo, 2020, Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19, Cell, 181, 1036, 10.1016/j.cell.2020.04.026 · DOI · Paper page
  75. L Angka, 2020, Is innate immunity our best weapon for flattening the curve?, J Clin Invest, 10.1172/JCI140530, 10.1172/JCI140530 · DOI
  76. S Achilli, 2020, TETRALEC, Artificial Tetrameric Lectins: A Tool to Screen Ligand and Pathogen Interactions, Int J Mol Sci, 19
  77. E Chabrol, 2012, Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode, PloS One, 7, e50722, 10.1371/journal.pone.0050722 · DOI
  78. M Maalej, 2019, Human Macrophage Galactose-Type Lectin (MGL) Recognizes the Outer Core of Escherichia coli Lipooligosaccharide, ChemBioChem, 20, 1778, 10.1002/cbic.201900087 · doi:10.1002/cbic.201900087
  79. JJ Reina, 2008, Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin, Org Biomol Chem, 6, 2743, 10.1039/b802144a · doi:10.1039/b802144a
  80. RC Valentine, 1968, Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli, Biochemistry, 7, 2143, 10.1021/bi00846a017 · DOI · Paper page
  81. K Zhang, 2016, Gctf: Real-time CTF determination and correction, J Struct Biol, 193, 1, 10.1016/j.jsb.2015.11.003 · DOI · Paper page
  82. MA Whitt, 2010, Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines, J Virol Methods, 169, 365, 10.1016/j.jviromet.2010.08.006 · DOI · Paper page
  83. N Varga, 2014, A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus, Biomaterials, 35, 4175, 10.1016/j.biomaterials.2014.01.014 · DOI

Cited by

See all 200

Metadata

Authors
Thépaut, M., Luczkowiak, J., Vivès, C., Labiod, N., Bally, I., Lasala, F., Grimoire, Y., Fenel, D., Sattin, S., Thielens, N., Schoehn, G., Bernardi, A., Delgado, R., & Fieschi, F.
Venue
PLOS Pathogens
Published
2021-05-20
Volume
17
Issue
5
Pages
e1009576
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W3163383906
Cited by
200
References
14
FWCI
12.14
Type
journal article
Language
en
Open access
gold
Funders
  • Grenoble Instruct-ERIC centre (ISBG; UMS 3518 CNRS-CEA-UGA-EMBL)
  • University Grenoble Alpes graduate school (FRISBI (ANR-10-INBS-05-02) and GRAL and ANR-17-EURE-0003)
  • Fondation Recherche Medicale (FEDER and the GIS-Infrastructures Biologie Sante et Agronomie (IBISA))
  • Agence Nationale de la Recherche (ANR-15-IDEX-02)
  • Instituto de Investigación Carlos III (FIS PI 1801007)
  • H2020 European Research Council (731868)
  • “la Caixa” Foundation (Project StopEbola)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. https://app.cochat.ai/papers/10.1371/journal.ppat.1009576
The paper
Thépaut, M., Luczkowiak, J., Vivès, C., Labiod, N., Bally, I., Lasala, F., Grimoire, Y., Fenel, D., Sattin, S., Thielens, N., Schoehn, G., Bernardi, A., Delgado, R., & Fieschi, F. (2021). DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1009576

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.